Yulong He

656 total citations
35 papers, 495 citations indexed

About

Yulong He is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yulong He has authored 35 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yulong He's work include Gastric Cancer Management and Outcomes (8 papers), Genetic factors in colorectal cancer (5 papers) and Enhanced Recovery After Surgery (4 papers). Yulong He is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Genetic factors in colorectal cancer (5 papers) and Enhanced Recovery After Surgery (4 papers). Yulong He collaborates with scholars based in China and France. Yulong He's co-authors include Lexing Li, Lihua He, Hanchuan Dai, Xueyi Wang, Danyang Liang, Changhua Zhang, Wen-hua Zhan, Loïc Reppel, N. de Isla and Yun Chen and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Gene.

In The Last Decade

Yulong He

34 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yulong He China 9 178 137 105 74 63 35 495
Laijun Song China 18 259 1.5× 126 0.9× 71 0.7× 83 1.1× 154 2.4× 49 711
Xiaotong Zhao China 15 200 1.1× 66 0.5× 75 0.7× 105 1.4× 115 1.8× 50 520
Zhiyuan Mao China 15 256 1.4× 114 0.8× 155 1.5× 81 1.1× 122 1.9× 46 736
Chenguang Li China 14 238 1.3× 164 1.2× 47 0.4× 96 1.3× 62 1.0× 29 594
Anne Lise Ferrara Italy 15 302 1.7× 67 0.5× 130 1.2× 38 0.5× 48 0.8× 39 795
Daijiro Hatakeyama Japan 18 395 2.2× 82 0.6× 137 1.3× 47 0.6× 79 1.3× 40 718
Mahmoud Al‐Azab China 12 273 1.5× 73 0.5× 82 0.8× 42 0.6× 80 1.3× 29 566
María Victoria Legorreta-Haquet Mexico 14 167 0.9× 108 0.8× 78 0.7× 100 1.4× 54 0.9× 26 704
Jia He China 17 211 1.2× 104 0.8× 42 0.4× 49 0.7× 54 0.9× 54 822
Danielle Callaway United States 10 392 2.2× 51 0.4× 116 1.1× 53 0.7× 66 1.0× 17 629

Countries citing papers authored by Yulong He

Since Specialization
Citations

This map shows the geographic impact of Yulong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulong He more than expected).

Fields of papers citing papers by Yulong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulong He. The network helps show where Yulong He may publish in the future.

Co-authorship network of co-authors of Yulong He

This figure shows the co-authorship network connecting the top 25 collaborators of Yulong He. A scholar is included among the top collaborators of Yulong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulong He. Yulong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Kuan, Zidan Zhao, Kexin Wang, et al.. (2024). m6A demethylation of NNMT in CAFs promotes gastric cancer progression by enhancing macrophage M2 polarization. Cancer Letters. 611. 217422–217422. 8 indexed citations
2.
Li, Bo, et al.. (2024). NAT10 Overexpression Promotes Tumorigenesis and Epithelial–Mesenchymal Transition Through AKT Pathway in Gastric Cancer. Digestive Diseases and Sciences. 69(9). 3261–3275. 1 indexed citations
4.
Jiang, Jianlong, Wenhui Wu, Mingzhe Li, et al.. (2020). RhoA mutations in diffuse-type gastric cancer. 3. 4–4. 2 indexed citations
5.
Liang, Danyang, Lihua He, Xueyi Wang, et al.. (2019). SIRT1/PGC-1 pathway activation triggers autophagy/mitophagy and attenuates oxidative damage in intestinal epithelial cells. Biochimie. 170. 10–20. 133 indexed citations
6.
Zhang, Changhua, et al.. (2017). 7rh, a novel selective discoidin domain receptor 1 (DDR1) inhibitor, enhances 5-fluorouracil response in gastric cancer. Annals of Oncology. 28. iii18–iii18. 2 indexed citations
7.
Huang, Xiaodan, et al.. (2017). Sclerosing angiomatoid nodular transformation of the spleen in a patient with Maffucci syndrome: a case report and review of literature. Diagnostic Pathology. 12(1). 79–79. 4 indexed citations
8.
Xu, Kaiwu, Zhihui Chen, Yi Cui, et al.. (2015). Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer. OncoTargets and Therapy. 8. 3047–3047. 30 indexed citations
9.
Zhang, Qingyuan, Jianbo Xu, Yujie Yuan, et al.. (2015). [Screening for predictive biomarkers of bevacizumab treatment in gastric cancer subcutaneous xenografts].. PubMed. 18(2). 177–80. 2 indexed citations
10.
Chen, Jianhui, et al.. (2013). [Application of enteral nutrition in preoperative bowel preparation for rectal cancer patients undergoing radical operation].. PubMed. 16(11). 1059–62. 2 indexed citations
11.
Yang, Dongjie, Weiling He, Jianbo Xu, et al.. (2013). [Effect of postoperative early enteral nutrition on the recovery of humoral immune function in patients with colorectal carcinoma undergoing elective resection].. PubMed. 16(11). 1051–4. 3 indexed citations
12.
Wu, Song, Suijing Wu, Yulong He, et al.. (2009). Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.. PubMed. 122(13). 1486–91. 64 indexed citations
13.
Wu, Song, Yulong He, Shirong Cai, et al.. (2009). [Clinical features of colorectal mucinous adenocarcinoma].. PubMed. 12(5). 487–90. 2 indexed citations
14.
Cai, Shirong, et al.. (2009). [Is albumin administration beneficial in early stage of postoperative hypoalbuminemia after gastrointestinal surgery: a prospective randomized control trial].. PubMed. 47(10). 744–7. 1 indexed citations
15.
Yang, Dongjie, et al.. (2009). Early operation for fulminant acute pancreatitis: a possible way to decrease mortality.. PubMed. 122(13). 1492–4. 2 indexed citations
16.
Zhang, Changhua, Yulong He, Dongjie Yang, et al.. (2008). Detection of hMSH2 and hMLH1 mutations in Chinese hereditary non-polyposis colorectal cancer kindreds. World Journal of Gastroenterology. 14(2). 298–298. 3 indexed citations
17.
Li, Yuming, Wen-hua Zhan, Fanghai Han, et al.. (2006). [Analysis of patterns, intervals and risk factors for recurrent gastric cancer].. PubMed. 44(3). 174–6. 1 indexed citations
18.
Cai, Shirong, et al.. (2003). [Clinical values of palliative gastrectomy for late-staged gastric cancer].. PubMed. 41(1). 27–9. 2 indexed citations
19.
Ma, Jian-ying, et al.. (2001). Telomerase activity and homozygous deletions of the p16 gene in liver metastases of colorectal carcinoma.. PubMed. 114(10). 1068–72. 1 indexed citations
20.
Xu, Peng, et al.. (2000). [Identification of telomerase activity in the experimental carcinogenesis of oral cavity].. PubMed. 18(1). 52–4, 57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026